Latest news
Fresenius receives FDA, EMA acceptance for review of vedolizumab biosimilar candidate - Drug Store NewsDrug Store News · Fri, 07 Aug 2026 14:04:51 GMTFresenius Kabi's Vedolizumab Biosimilar Clears FDA and EMA Review Milestone - BioPharma APACBioPharma APAC · Tue, 04 Aug 2026 21:27:58 GMTPolpharma and Fresenius Kabi's Vedolizumab Biosimilar PB016 Clears FDA, EMA Review Acceptance - BioPharm InternationalBioPharm International · Fri, 31 Jul 2026 16:17:12 GMTFresenius announces FDA, EMA acceptance of vedolizumab biosimilar for review - TipRanksTipRanks · Fri, 31 Jul 2026 12:47:38 GMTFresenius Announces FDA and EMA Acceptance for Review of Vedolizumab Biosimilar Candidate - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 11:00:00 GMTPolpharma Biologics’ Entyvio biosimilar accepted for FDA, EMA review - The Pharma LetterThe Pharma Letter · Fri, 31 Jul 2026 07:00:00 GMTPolpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT